These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2509079)
1. Human phagocyte oxidative burst activation by BCG, M. leprae, and atypical mycobacteria: defective activation by M. leprae is not reversed by interferon gamma. Launois P; Maillere B; Dieye A; Sarthou JL; Bach MA Cell Immunol; 1989 Nov; 124(1):168-74. PubMed ID: 2509079 [TBL] [Abstract][Full Text] [Related]
2. TNF-alpha failed to reverse the M. leprae-induced defective chemiluminescence response of human mononuclear cells. Launois P; Niang M; Dieye A; Sarthou JL FEMS Microbiol Immunol; 1992 Jan; 4(2):91-6. PubMed ID: 1547026 [TBL] [Abstract][Full Text] [Related]
3. Human phagocyte respiratory burst by Mycobacterium bovis BCG and M. leprae: functional activation by BCG is mediated by complement and its receptors on monocytes. Launois P; Niang M; Dieye A; Sarthou JL; Rivier F; Millan J Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):225-33. PubMed ID: 1522364 [TBL] [Abstract][Full Text] [Related]
4. Phenolic glycolipid-1 from M. leprae inhibits oxygen free radical production by human mononuclear cells. Launois P; Blum L; Dieye A; Millan J; Sarthou JL; Bach MA Res Immunol; 1989; 140(9):847-55. PubMed ID: 2697907 [TBL] [Abstract][Full Text] [Related]
5. Human phagocytic cell responses to Mycobacterium leprae and Mycobacterium bovis Bacillus Calmette-Guérin. An in vitro comparison of leprosy vaccine components. Holzer TJ; Kizlaitis L; Vachula M; Weaver CW; Andersen BR J Immunol; 1988 Sep; 141(5):1701-8. PubMed ID: 3137262 [TBL] [Abstract][Full Text] [Related]
7. The influence of killed Mycobacterium leprae and other mycobacteria on opsonized yeast phagocytosis. Cree IA; Beck JS Clin Exp Immunol; 1986 Apr; 64(1):35-40. PubMed ID: 3524918 [TBL] [Abstract][Full Text] [Related]
8. [Macrophage activation and Mycobacterium leprae: effect of interferon gamma on the production of oxygen free radicals by phagocytic cells]. Launois P; Dieye A; Blum L; Millan J; Sarthou JL Dakar Med; 1989; 34(1-4):78-82. PubMed ID: 2518818 [TBL] [Abstract][Full Text] [Related]
9. Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults. Black GF; Weir RE; Chaguluka SD; Warndorff D; Crampin AC; Mwaungulu L; Sichali L; Floyd S; Bliss L; Jarman E; Donovan L; Andersen P; Britton W; Hewinson G; Huygen K; Paulsen J; Singh M; Prestidge R; Fine PE; Dockrell HM Clin Diagn Lab Immunol; 2003 Jul; 10(4):602-11. PubMed ID: 12853392 [TBL] [Abstract][Full Text] [Related]
10. M. leprae- and BCG-induced chemiluminescence response of monocytes from leprosy patients and healthy subjects: effects of gamma-interferon and GM-CSF. Launois P; Blum L; Dieye A; Millan J; Sarthou JL; Michel JC; Bach MA Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):582-9. PubMed ID: 1802941 [TBL] [Abstract][Full Text] [Related]
11. Opposite effects of M. leprae or M. bovis BCG delipidation on cellular accumulation into mouse pleural cavity. Distinct accomplishment of mycobacterial lipids in vivo. Moura AC; Leonardo PS; Henriques MG; Cordeiro RS Inflamm Res; 1999 Jun; 48(6):308-13. PubMed ID: 10442482 [TBL] [Abstract][Full Text] [Related]
12. Mycobacterium leprae renders Schwann cells and mononuclear phagocytes susceptible or resistant to killer cells. Steinhoff U; Wand-Württenberger A; Bremerich A; Kaufmann SH Infect Immun; 1991 Feb; 59(2):684-8. PubMed ID: 1898912 [TBL] [Abstract][Full Text] [Related]
13. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines. Mustafa AS Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259 [TBL] [Abstract][Full Text] [Related]
14. Mycobacterium leprae phenolglycolipid-1 expressed by engineered M. bovis BCG modulates early interaction with human phagocytes. Tabouret G; Astarie-Dequeker C; Demangel C; Malaga W; Constant P; Ray A; Honoré N; Bello NF; Perez E; Daffé M; Guilhot C PLoS Pathog; 2010 Oct; 6(10):e1001159. PubMed ID: 20975946 [TBL] [Abstract][Full Text] [Related]
15. T cell response to purified filtrate antigen 85 from Mycobacterium bovis Bacilli Calmette-Guérin (BCG) in leprosy patients. Launois P; Huygen K; De Bruyn J; N'Diaye M; Diouf B; Sarthouj L; Grimaud J; Millan J Clin Exp Immunol; 1991 Nov; 86(2):286-90. PubMed ID: 1934596 [TBL] [Abstract][Full Text] [Related]
16. M. leprae inhibits apoptosis in THP-1 cells by downregulation of Bad and Bak and upregulation of Mcl-1 gene expression. Hasan Z; Ashraf M; Tayyebi A; Hussain R BMC Microbiol; 2006 Sep; 6():78. PubMed ID: 16978419 [TBL] [Abstract][Full Text] [Related]
17. Mycobacterium bovis BCG but not Mycobacterium leprae induces TNF-alpha secretion in human monocytic THP-1 cells. Oliveira MM; Charlab R; Pessolani MC Mem Inst Oswaldo Cruz; 2001 Oct; 96(7):973-8. PubMed ID: 11685264 [TBL] [Abstract][Full Text] [Related]
18. Mycobacterium xenopi and BCG, pathogens of the future? Lancet; 1985 Jan; 1(8421):174-5. PubMed ID: 2857256 [No Abstract] [Full Text] [Related]
19. Oxidation of various substrates by host grown Mycobacteria leprae and M. lepraemurium. Ishaque M; Kato L Rev Can Biol; 1977 Sep; 36(3):277-82. PubMed ID: 337415 [TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen intermediates inactivate Mycobacterium leprae in the phagocytes from human peripheral blood. Marolia J; Mahadevan PR Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):483-91. PubMed ID: 2664043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]